Works matching DE "ERLOTINIB"

Results: 1025

Coca-Cola for Lung Cancer?

Published in:: RT: The Journal for Respiratory Care Practitioners, 2016, v. 29, n. 3, p. 34
Publication type:: Article

Erlotinib-induced purpuric papulopustular eruption treated with pulsed azithromycin.

Published in:

Indian Journal of Pharmacology, 2016, v. 48, n. 3, p. 324, doi. 10.4103/0253-7613.182887

By:

Akoglu, Gulsen;
Yavuz, Sibel Orhun;
Metin, Ahmet

Publication type:

Article

Real-time identification of aberrant left hepatic arterial territories using near-infrared fluorescence with indocyanine green during gastrectomy for gastric cancer.

Published in:

Surgical Endoscopy & Other Interventional Techniques, 2021, v. 35, n. 5, p. 2389, doi. 10.1007/s00464-020-08265-1

By:

Lee, Joong Ho;
Son, Taeil;
Chung, Yong Eun;
Cho, Minah;
Kim, Yoo Min;
Kwon, In Gyu;
Kim, Hyoung-Il;
Hyung, Woo Jin

Publication type:

Article

MiRNA‐7 enhances erlotinib sensitivity of glioblastoma cells by blocking the IRS‐1 and IRS‐2 expression.

Published in:

Journal of Pharmacy & Pharmacology, 2020, v. 72, n. 4, p. 531, doi. 10.1111/jphp.13226

By:

Alamdari‐Palangi, Vahab;
Amini, Razieh;
Karami, Hadi

Publication type:

Article

Targeting EphA2 with miR‐124 mediates Erlotinib resistance in K‐RAS mutated pancreatic cancer.

Published in:

Journal of Pharmacy & Pharmacology, 2019, v. 71, n. 2, p. 196, doi. 10.1111/jphp.12941

By:

Du, Jing;
He, Yuanqiao;
Wu, Weiquan;
Li, Peng;
Chen, Youwei;
Hu, Zhiming;
Han, Yong

Publication type:

Article

Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis.

Published in:

NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00301-8

By:

Zhang, Chao;
Chen, Hua-Fei;
Yan, Shi;
Wu, Lin;
Yan, Li-Xu;
Yan, Xiao-Long;
Yue, Dong-Sheng;
Xu, Chun-Wei;
Zheng, Min;
Li, Ji-Sheng;
Liu, Si-Yang;
Yang, Ling-Ling;
Jiang, Ben-Yuan;
Ou, Qiu-Xiang;
Qiu, Zhen-Bin;
Shao, Yang;
Wu, Yi-Long;
Zhong, Wen-Zhao

Publication type:

Article

Novel Analytical Method Development, Validation and Stability Study of Anticancer Drug Erlotinib in Tablet Dosage Form by RP-UFLC.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2021, v. 55, p. S589, doi. 10.5530/ijper.55.2s.131

By:

Purvini K.;
Chethan I. A.;
Vaijanathappa, Jaishree

Publication type:

Article

Coumarin-Piperazine Tethered 1,2,3-Triazoles: EGFR Targeting Anti-Breast Cancer Evaluation and Molecular Docking Studies.

Published in:

Polycyclic Aromatic Compounds, 2024, v. 44, n. 8, p. 5487, doi. 10.1080/10406638.2023.2265026

By:

Gangadhar, Kotni Hari;
Benarjee, Velaga;
Ratnamala, Annapragada

Publication type:

Article

Synthesis of 4-Azaindole-Thiazolidine-2,4-Dione Coupled 1,2,3-Triazoles as EGFR Directing Anticancer Agents.

Published in:

Polycyclic Aromatic Compounds, 2024, v. 44, n. 8, p. 5009, doi. 10.1080/10406638.2023.2259563

By:

Shreedhar Reddy, T.;
Rai, Sanjay;
Koppula, Shiva Kumar

Publication type:

Article

Organocatalytic [3 + 2] Cycloaddition Reaction: Synthesis of Fully Decorated Sulfonyl-1,2,3-Triazolyl Pyrimidines as Potent Anticancer and EGFR Inhibitors.

Published in:

Polycyclic Aromatic Compounds, 2024, v. 44, n. 4, p. 2675, doi. 10.1080/10406638.2023.2220864

By:

Velidandla, Jagan Mohan Reddy;
Koppula, Shiva Kumar

Publication type:

Article

Synthesis and Biological Evaluation of Novel N-[3-fluoro-4-(morpholin-4-yl)phenyl]thiazol-2-amine Derivatives as Potent Antibacterial and Anticancer Agents and ADMET.

Published in:

Polycyclic Aromatic Compounds, 2024, v. 44, n. 1, p. 117, doi. 10.1080/10406638.2023.2169473

By:

Nellutla, Manoj Kumar;
Kamarajugadda, Pavan;
Soma, Laxminarayana;
Haridasyam, Ramesh Babu;
Narsimha, Sirassu

Publication type:

Article

Synthesis of N-Methylene Linker Containing Phthalimide Bearing-1H-1,2,3-Triazole by Click Chemistry Approach: Anticancer Activity in Human Cells.

Published in:

Polycyclic Aromatic Compounds, 2023, v. 43, n. 6, p. 5354, doi. 10.1080/10406638.2022.2101487

By:

Mori, Navneet P.;
Parmar, Priti K.;
Khedkar, Vijay M.;
Khunt, Ranjan C.

Publication type:

Article

Successful treatment of solar urticaria with UVA1 hardening in three patients.

Published in:

Photodermatology, Photoimmunology & Photomedicine, 2019, v. 35, n. 3, p. 193, doi. 10.1111/phpp.12447

By:

Lyons, Alexis B.;
Peacock, Anjelica;
Zubair, Raheel;
Hamzavi, Iltefat H.;
Lim, Henry W.

Publication type:

Article

Treatment of erlotinib‐induced acneiform eruption with chromophore gel‐assisted phototherapy.

Published in:

2019

By:

Mahendran, Akalya;
Wong, Xin L.;
Kao, Steven;
Sebaratnam, Deshan F.

Publication type:

Letter to the Editor

Potential Use of Hyperspectral Reflectance as a High-Throughput Nondestructive Phenotyping Tool for Assessing Salt Tolerance in Advanced Spring Wheat Lines under Field Conditions.

Published in:

Plants (2223-7747), 2021, v. 10, n. 11, p. 2512, doi. 10.3390/plants10112512

By:

El-Hendawy, Salah;
Al-Suhaibani, Nasser;
Mubushar, Muhammad;
Tahir, Muhammad Usman;
Refay, Yahya;
Tola, ElKamil

Publication type:

Article

Cu‐Catalyzed Synthesis of 4H‐benzo[4,5]thiazolo[3,2‐a]pyrimidin‐4‐ones: Molecular Docking Studies and Anti‐Proliferative Activities Against HepG2 Hepatocellular Carcinoma Cells.

Published in:

Asian Journal of Organic Chemistry, 2024, v. 13, n. 6, p. 1, doi. 10.1002/ajoc.202400065

By:

Aljaar, Nayyef;
Aboalrub, Husam F.;
Shtaiwi, Majed;
Sarhan, Ayman H. Abu;
Younes, Eyad A.;
Al‐Noaimi, Mousa;
Shtaiwi, Amneh;
Tahtamouni, Lubna H.;
Abu‐Safieh, Kayed A.;
AlObaid, Abeer A.;
Malakar, Chandi C.

Publication type:

Article

A Pharmacokinetic Interaction Study of Sorafenib and Iced Teas in Rats Using UPLC-MS/MS: An Illustration of Beverage-Drug Interaction.

Published in:

BioMed Research International, 2019, p. 1, doi. 10.1155/2019/2410845

By:

Maher, Hadir M.;
Almomen, Aliyah;
Alzoman, Nourah Z.;
Shehata, Shereen M.;
Al-Subaie, Amal

Publication type:

Article

A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer.

Published in:

Cancer Biology & Medicine, 2022, v. 19, n. 2, p. 136, doi. 10.20892/j.issn.2095-3941.2021.0520

By:

Yuchen Guo;
Yangyang Zhou;
Wenxin Qin

Publication type:

Article

Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling.

Published in:

Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 753, doi. 10.20892/j.issn.2095-3941.2020.0024

By:

Tingting Qin;
Zhujun Liu;
Jing Wang;
Junling Xia;
Shaochuan Liu;
Yanan Jia;
Hailin Liu;
Kai Li

Publication type:

Article

Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI.

Published in:

Cancer Biology & Medicine, 2014, v. 11, n. 4, p. 270

By:

Guo-Hao Xia;
Yun Zeng;
Ying Fang;
Shao-Rong Yu;
Li Wang;
Mei-Qi Shi;
Wei-Li Sun;
Xin-En Huang;
Jia Chen;
Ji-Feng Feng

Publication type:

Article

EGFR inhibitors erlotinib and lapatinib ameliorate epidermal blistering in pemphigus vulgaris in a non-linear, V-shaped relationship.

Published in:

Experimental Dermatology, 2014, v. 23, n. 1, p. 33, doi. 10.1111/exd.12290

By:

Sayar, Beyza S.;
Rüegg, Simon;
Schmidt, Enno;
Sibilia, Maria;
Siffert, Myriam;
Suter, Maja M.;
Galichet, Arnaud;
Müller, Eliane J.

Publication type:

Article

Olmsted Syndrome: Response to erlotinib therapy and genotype/phenotype correlation.

Published in:: Australasian Journal of Dermatology, 2021, v. 62, n. 3, p. 445, doi. 10.1111/ajd.13663
Publication type:: Article

Synthesis and Evaluation of Some Novel 6-Substituted Quinazoline Derivatives as Antitumor Agents.

Published in:

Journal of the Chemical Society of Pakistan, 2019, v. 41, n. 1, p. 186, doi. 10.52568/000716/jcsp/41.01.2019

By:

Ding, Hai-guan;
Cai, Zhi-qiang;
Hou, Ling;
Hu, Zhi-quan;
Jin, Zheng-sheng;
Xu, Di;
Cao, Hui;
Meng, Miao-miao;
Xie, Yu-Hui;
Zheng, De-qiang

Publication type:

Article

Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy.

Published in:

Lung Cancer: Targets & Therapy, 2017, v. 8, p. 109, doi. 10.2147/LCTT.S119644

By:

Santarpia, Mariacarmela;
Liguori, Alessia;
Karachaliou, Niki;
Gonzalez-Cao, Maria;
Daffinà, Maria Grazia;
D'Aveni, Alessandro;
Marabello, Grazia;
Altavilla, Giuseppe;
Rosell, Rafael

Publication type:

Article

Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics.

Published in:

Lung Cancer: Targets & Therapy, 2014, v. 5, p. 73, doi. 10.2147/LCTT.S50671

By:

Karachaliou, Niki;
Rosell, Rafael

Publication type:

Article

The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.

Published in:

Cancer Research & Treatment, 2023, v. 55, n. 2, p. 479, doi. 10.4143/crt.2022.1344

By:

Hyun Ae Jung;
Sehhoon Park;
Se-Hoon Lee;
Jin Seok Ahn;
Myung-Ju Ahn;
Jong-Mu Sun

Publication type:

Article

The Impact of EGFR Tyrosine Kinase Inhibitor on the Natural Course of Concurrent Subsolid Nodules in Patients with Non–Small Cell Lung Cancer.

Published in:

Cancer Research & Treatment, 2022, v. 54, n. 3, p. 817, doi. 10.4143/crt.2021.822

By:

Noeul Kang;
Ki Hwan Kim;
Byeong-Ho Jeong;
Kyungjong Lee;
Hojoong Kim;
O Jung Kwon;
Myung-Ju Ahn;
Jeonghee Cho;
Ho Yun Lee;
Sang-Won Um

Publication type:

Article

Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells.

Published in:

Cancer Research & Treatment, 2021, v. 53, n. 2, p. 457, doi. 10.4143/crt.2020.585

By:

Boonsri, Boonyakorn;
Yacqub-Usman, Kiren;
Thintharua, Pakpoom;
Kyaw Zwar Myint;
Sae-Lao, Thannicha;
Collier, Pam;
Suriyonplengsaeng, Chinnawut;
Larbcharoensub, Noppadol;
Balasubramanian, Brinda;
Venkatraman, Simran;
Egbuniwe, Isioma U.;
Gomez, Dhanwant;
Mukherjee, Abhik;
Kumkate, Supeecha;
Janvilisri, Tavan;
Zaitoun, Abed M.;
Kuakpaetoon, Thiti;
Tohtong, Rutaiwan;
Grabowska, Anna M.;
Bates, David O.

Publication type:

Article

Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients.

Published in:

Cancer Research & Treatment, 2019, v. 51, n. 4, p. 1549, doi. 10.4143/crt.2019.086

By:

Yeonjoo Choi;
Bhumsuk Keam;
Miso Kim;
Shinkyo Yoon;
Dalyong Kim;
Jong Gwon Choi;
Ja Young Seo;
Inkeun Park;
Jae Lyun Lee

Publication type:

Article

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib.

Published in:

Cancer Research & Treatment, 2019, v. 51, n. 2, p. 502, doi. 10.4143/crt.2018.117

By:

Youjin Kim;
Se-Hoon Lee;
Jin Seok Ahn;
Myung-Ju Ahn;
Keunchil Park;
Jong-Mu Sun

Publication type:

Article

Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status.

Published in:

Cancer Research & Treatment, 2017, v. 49, n. 4, p. 981, doi. 10.4143/crt.2016.522

By:

Youngjoo Lee;
Ji-Youn Han;
Sung Ho Moon;
Byung-Ho Nam;
Kun Young Lim;
Geon Kook Lee;
Heung Tae Kim;
Tak Yun;
Hye Jin An;
Jin Soo Lee

Publication type:

Article

Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial

Published in:

Cancer Research & Treatment, 2015, v. 47, n. 4, p. 616, doi. 10.4143/crt.2014.051

By:

Dae Ho Lee;
Jung Shin Lee;
Jie Wang;
Te-Chun Hsia;
Xin Wang;
Jongseok Kim;
Mauro Orlando

Publication type:

Article

Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer.

Published in:

Cancer Research & Treatment, 2015, v. 47, n. 2, p. 266, doi. 10.4143/crt.2013.158

By:

Jae Yun Lim;
Jang Ho Cho;
Se Joon Lee;
Dong Ki Lee;
Dong Sup Yoon;
Jae Yong Cho

Publication type:

Article

Multifunctional magnetic nanoparticles for MRI-guided co-delivery of erlotinib and L-asparaginase to ovarian cancer.

Published in:

Journal of Microencapsulation, 2022, v. 39, n. 4, p. 394, doi. 10.1080/02652048.2022.2094487

By:

Mohaghegh, Seraj;
Tarighatnia, Ali;
Omidi, Yadollah;
Barar, Jaleh;
Aghanejad, Ayuob;
Adibkia, Khosro

Publication type:

Article

Targeted combined therapy in 2D and 3D cultured MCF-7 cells using metformin and erlotinib-loaded mesoporous silica magnetic nanoparticles.

Published in:

Journal of Microencapsulation, 2021, v. 38, n. 7/8, p. 472, doi. 10.1080/02652048.2021.1979672

By:

Hashemzadeh, Nastaran;
Aghanejad, Ayuob;
Dalir Abdolahinia, Elaheh;
Dolatkhah, Mitra;
Barzegar-Jalali, Mohammad;
Omidi, Yadollah;
Barar, Jaleh;
Adibkia, Khosro

Publication type:

Article

Cancer Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK DEFINE Database.

Published in:

Cancers, 2025, v. 17, n. 2, p. 311, doi. 10.3390/cancers17020311

By:

Chan, Stefanie Ho Yi;
Fitzpatrick, Raymond W.;
Layton, Deborah;
Webley, Sherael;
Salek, Sam

Publication type:

Article

ARAF Amplification in Small-Cell Lung Cancer-Transformed Tumors Following Resistance to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors.

Published in:

Cancers, 2024, v. 16, n. 20, p. 3501, doi. 10.3390/cancers16203501

By:

Kimura, Ryo;
Adachi, Yuta;
Hirade, Kentaro;
Kisoda, Satoru;
Yanase, Shogo;
Shibata, Noriko;
Ishii, Makoto;
Fujiwara, Yutaka;
Yamaguchi, Rui;
Fujita, Yasuko;
Hosoda, Waki;
Ebi, Hiromichi

Publication type:

Article

Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea.

Published in:

Cancers, 2024, v. 16, n. 18, p. 3173, doi. 10.3390/cancers16183173

By:

Park, Chan Su;
Park, Byung Kyu;
Han, Joung-Ho;
Lee, Kyong Joo;
Son, Kang Ju

Publication type:

Article

Transcriptomic Analysis Reveals Early Alterations Associated with Intrinsic Resistance to Targeted Therapy in Lung Adenocarcinoma Cell Lines.

Published in:

Cancers, 2024, v. 16, n. 13, p. 2490, doi. 10.3390/cancers16132490

By:

Perez-Medina, Mario;
Lopez-Gonzalez, Jose S.;
Benito-Lopez, Jesus J.;
Ávila-Ríos, Santiago;
Soto-Nava, Maribel;
Matias-Florentino, Margarita;
Méndez-Tenorio, Alfonso;
Galicia-Velasco, Miriam;
Chavez-Dominguez, Rodolfo;
Meza-Toledo, Sergio E.;
Aguilar-Cazares, Dolores

Publication type:

Article

Optimal Treatment Strategy for Oligo-Recurrence Lung Cancer Patients with Driver Mutations.

Published in:

Cancers, 2024, v. 16, n. 2, p. 464, doi. 10.3390/cancers16020464

By:

Tachibana, Taimei;
Matsuura, Yosuke;
Ninomiya, Hironori;
Ichinose, Junji;
Nakao, Masayuki;
Okumura, Sakae;
Nishio, Makoto;
Ikeda, Norihiko;
Mun, Mingyon

Publication type:

Article

Treatment Strategies for Non-Small Cell Lung Cancer with Common EGFR Mutations: A Review of the History of EGFR TKIs Approval and Emerging Data.

Published in:

Cancers, 2023, v. 15, n. 3, p. 629, doi. 10.3390/cancers15030629

By:

Marin-Acevedo, Julian A.;
Pellini, Bruna;
Kimbrough, ErinMarie O.;
Hicks, J. Kevin;
Chiappori, Alberto

Publication type:

Article

The Clinical Impact of Methylated Homeobox A9 ctDNA in Patients with Non-Resectable Biliary Tract Cancer Treated with Erlotinib and Bevacizumab.

Published in:

Cancers, 2022, v. 14, n. 19, p. 4598, doi. 10.3390/cancers14194598

By:

Andersen, Line Bechsgaard;
Mahler, Marit Sofie Kjær;
Andersen, Rikke Fredslund;
Jensen, Lars Henrik;
Raunkilde, Louise

Publication type:

Article

NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma.

Published in:

Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184395

By:

Jiang, Shiyao;
Huang, Jingjing;
He, Hua;
Liu, Yueying;
Liang, Lu;
Sun, Xiaoyan;
Li, Yi;
Cong, Li;
Qing, Bei;
Jiang, Yiqun

Publication type:

Article

EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer.

Published in:

Cancers, 2022, v. 14, n. 16, p. 3943, doi. 10.3390/cancers14163943

By:

Selenz, Carolin;
Compes, Anik;
Nill, Marieke;
Borchmann, Sven;
Odenthal, Margarete;
Florin, Alexandra;
Brägelmann, Johannes;
Büttner, Reinhard;
Meder, Lydia;
Ullrich, Roland T.

Publication type:

Article

Emergence of Resistance to MTI-101 Selects for a MET Genotype and Phenotype in EGFR Driven PC-9 and PTEN Deleted H446 Lung Cancer Cell Lines.

Published in:

Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133062

By:

Jones, Clark;
Dziadowicz, Sebastian;
Suite, Samuel;
Eby, Ashley;
Chen, Wei-Chih;
Hu, Gangqing;
Hazlehurst, Lori A.

Publication type:

Article

Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI.

Published in:

Cancers, 2022, v. 14, n. 4, p. 977, doi. 10.3390/cancers14040977

By:

Chang, John Wen-Cheng;
Huang, Chen-Yang;
Fang, Yueh-Fu;
Chang, Ching-Fu;
Yang, Cheng-Ta;
Kuo, Chih-Hsi Scott;
Hsu, Ping-Chih;
Wu, Chiao-En

Publication type:

Article

Renal Safety Profile of EGFR Targeted Therapies: A Study from VigiBase ® the WHO Global Database of Individual Case Safety Reports.

Published in:

Cancers, 2021, v. 13, n. 23, p. 5907, doi. 10.3390/cancers13235907

By:

Crosnier, Alexandre;
Abbara, Chadi;
Cellier, Morgane;
Lagarce, Laurence;
Babin, Marina;
Bourneau-Martin, Delphine;
Briet, Marie

Publication type:

Article

Molecular Mechanism of EGFR-TKI Resistance in EGFR -Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring.

Published in:

Cancers, 2021, v. 13, n. 19, p. 4926, doi. 10.3390/cancers13194926

By:

Reita, Damien;
Pabst, Lucile;
Pencreach, Erwan;
Guérin, Eric;
Dano, Laurent;
Rimelen, Valérie;
Voegeli, Anne-Claire;
Vallat, Laurent;
Mascaux, Céline;
Beau-Faller, Michèle

Publication type:

Article

Erlotinib Promotes Ligand-Induced EGFR Degradation in 3D but Not 2D Cultures of Pancreatic Ductal Adenocarcinoma Cells.

Published in:

Cancers, 2021, v. 13, n. 18, p. 4504, doi. 10.3390/cancers13184504

By:

Betriu, Nausika;
Andreeva, Anna;
Semino, Carlos E.

Publication type:

Article

Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma.

Published in:

Cancers, 2021, v. 13, n. 16, p. 3978, doi. 10.3390/cancers13163978

By:

Rausch, Magdalena;
Rutz, Adriano;
Allard, Pierre-Marie;
Delucinge-Vivier, Céline;
Docquier, Mylène;
Dormond, Olivier;
Dyson, Paul J.;
Wolfender, Jean-Luc;
Nowak-Sliwinska, Patrycja

Publication type:

Article